Manfredo Martin-Michael Madrigal, 38, formerly of Charlottesville, Va., pled guilty in July 2024 to one count of destruction of U.S. Army materials and three counts of making a false statement.
Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers ...
CONSHOHOCKEN, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction ...
Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full ...
La Edison Next, società del gruppo Edison che si occupa di decarbonizzazione e transizione ecologica per le aziende, ha ottenuto una nuova tranche di contributi previsti dal Pnrr: 2,3 milioni di ...
La commedia arriva al cinema senza nessuna attività stampa: solo proiezioni in sala con pubblico pagante. Precedute da una serie di manifesti con il volto di Angelo Duro che indossa i consueti ...
Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target of $427.00. Discover outperforming stocks and invest ...
Il sindaco Roberto Lagalla, insieme alla Direzione generale, ha fatto il punto sugli investimenti derivanti da risorse extra-comunali, incontrando gli uffici responsabili del monitoraggio e della ...
Rezdiffra's strong launch has been confirmed by robust sales in the first two quarters, even though it may have only been used in 2% of its current target patient population. Competitors with MASH ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results